Innorubicin 50mg Injection
Marketer
Innova Formulations Pvt Ltd
Salt Composition
Epirubicin (50mg)
Overview Innorubicin 50mg Injection
Doxorubicin hydrochloride 50mg injection is indicated for treating diverse hematologic malignancies and cancers affecting the breast, stomach, lungs, ovaries, and soft tissues. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a qualified healthcare professional via infusion, it's used either singularly or in conjunction with other medications as part of a combination chemotherapy regimen. Dosage and frequency are determined by your physician based on your specific condition and may vary. Adhere strictly to your prescribed dosage; improper use or overdose can result in severe adverse reactions. While benefits may not be immediately apparent (weeks or months), discontinue use only under your doctor's direction. Note that this medication can compromise the effectiveness of oral contraceptives; reliable contraception is advised for both men and women undergoing treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and dermatological reactions. The medication can decrease blood cell counts, elevating infection risk, potentially life-threatening. Regular blood tests are necessary to monitor blood cell levels and the function of your kidneys, liver, and heart. Prior to treatment, disclose any pre-existing liver or heart conditions to your doctor, as well as all other medications you're currently taking, since interactions can impact efficacy or alter drug metabolism. Notify your physician if you are pregnant or breastfeeding.
Primary Ingredients of Innorubicin 50mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Innorubicin 50mg Injection
Malignant neoplasm
Major Benefits of Innorubicin 50mg Injection:
Administering this medication will be handled by your healthcare provider. Please do not attempt self-medication.
Common Side effects of Innorubicin 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Innorubicin 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Innorubicin 50mg Injection works:
Innorubicin 50mg Injection, an antineoplastic agent, inhibits the action of topoisomerase II, a crucial enzyme in breast cancer cell DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, ultimately arresting and eliminating breast cancer cell proliferation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Innorubicin 50mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Innorubicin 50mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use justifiable if potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Innorubicin 50mg Injection. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Innorubicin 50mg Injection can produce adverse reactions that might impact driving capabilities. Nausea and vomiting, potential side effects of Innorubicin 50mg Injection, may temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
The use of Innorubicin 50mg Injection in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification for Innorubicin 50mg Injection might be unnecessary in such cases. However, medical advice is recommended. A reduced dosage may be warranted for patients exhibiting serum creatinine levels exceeding 5 mg/dL.
LiverCAUTION
Patients with liver impairment should receive Innorubicin 50mg Injection with close monitoring. Dosage modification may be necessary. Physician consultation is advised. Innorubicin 50mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Innorubicin 50mg Injection :
NA
Facts to Know About Innorubicin 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently